237 related articles for article (PubMed ID: 2349963)
1. Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.
Cohn SL; Rademaker AW; Salwen HR; Franklin WA; Gonzales-Crussi F; Rosen ST; Bauer KD
Am J Pathol; 1990 May; 136(5):1043-52. PubMed ID: 2349963
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
Bourhis J; De Vathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; McNally NJ; Lemerle J; Riou G; Bénard J
Cancer Res; 1991 Jan; 51(1):33-6. PubMed ID: 1988094
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric and molecular analysis of proliferative activity and DNA content in neuroblastoma: presence of stationary cells in S-phase.
Dominici C; Negroni A; Romeo A; McDowell H; Padula A; Pucci S; Cappelli C; Castello MA; Raschellà G
Anticancer Res; 1992; 12(1):59-63. PubMed ID: 1567182
[TBL] [Abstract][Full Text] [Related]
5. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
[TBL] [Abstract][Full Text] [Related]
6. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
7. Retrospective study on amplification of N-myc and c-myc genes in pediatric solid tumors and its association with prognosis and tumor differentiation.
Tsuda H; Shimosato Y; Upton MP; Yokota J; Terada M; Ohira M; Sugimura T; Hirohashi S
Lab Invest; 1988 Sep; 59(3):321-7. PubMed ID: 3411933
[TBL] [Abstract][Full Text] [Related]
8. [Oncogen N-myc expression and measurement of DNA ploidy in neuroblastoma: a double staining flow cytometric analysis].
Chassevent A; Bénard J
Bull Cancer; 1997 Mar; 84(3):29-34. PubMed ID: 9207866
[TBL] [Abstract][Full Text] [Related]
9. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
[TBL] [Abstract][Full Text] [Related]
10. myc gene amplification and expression in primary human neuroblastoma.
Slavc I; Ellenbogen R; Jung WH; Vawter GF; Kretschmar C; Grier H; Korf BR
Cancer Res; 1990 Mar; 50(5):1459-63. PubMed ID: 2302711
[TBL] [Abstract][Full Text] [Related]
11. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
12. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
[TBL] [Abstract][Full Text] [Related]
13. DNA ploidy in neuroblastoma.
Eckschlager T; Pilát D; Kodet R; Dahbiová R; Stanková J; Jasinská J; Hrusák O
Neoplasma; 1996; 43(1):23-6. PubMed ID: 8843955
[TBL] [Abstract][Full Text] [Related]
14. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
15. Investigation of co-amplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. United Kingdom Children's Cancer Study Group.
George RE; Kenyon RM; McGuckin AG; Malcolm AJ; Pearson AD; Lunec J
Oncogene; 1996 Apr; 12(7):1583-7. PubMed ID: 8622876
[TBL] [Abstract][Full Text] [Related]
16. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
[TBL] [Abstract][Full Text] [Related]
17. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
18. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
20. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR.
Sartelet H; Grossi L; Pasquier D; Combaret V; Bouvier R; Ranchère D; Plantaz D; Munzer M; Philip T; Birembaut P; Zahm JM; Bergeron C; Gaillard D; Pasquier B
J Pathol; 2002 Sep; 198(1):83-91. PubMed ID: 12210067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
